Engineers Gate Manager’s KalVista Pharmaceuticals KALV Stock Holding History

Engineers Gate Manager’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,180	Closed	-$225K	–	2428
2026 Q1	$225K	Buy	+11,180	New	+$180K	﹤0.01%	1857
2025 Q3	–	Sell	-26,257	Closed	-$297K	–	2355
2025 Q2	$297K	Buy	26,257 +415	+2%	+$5.07K	﹤0.01%	1735
2025 Q1	$298K	Buy	+25,842	New	+$264K	0.01%	1708
2022 Q3	–	Sell	-16,721	Closed	-$165K	–	1853
2022 Q2	$165K	Buy	+16,721	New	+$184K	0.01%	1660

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Engineers Gate Manager's KALV Position: Q2 2026 in Review

Engineers Gate Manager sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 11,180 shares — an estimated $225K sold.

Engineers Gate Manager first reported a position in KALV in Q2 2022 and held it in 4 quarters. The position peaked at $298K in Q1 2025. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Engineers Gate Manager reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Engineers Gate Manager sold 11,180 KalVista Pharmaceuticals shares in Q2 2026, an estimated $225K.
Engineers Gate Manager first reported a position in KalVista Pharmaceuticals in Q2 2022 and held it in 4 quarters.
Engineers Gate Manager's KalVista Pharmaceuticals position peaked at $298K in Q1 2025.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.